In April 2013 a so-called “Dear Doctor” letter was sent out in Canada by Novartis Pharmaceuticals Canada Inc. warning about some serious side effects associated with Tasigna and a drug label change with new information concerning those Tasigna side effects. Significantly, there was no similar “Dear Doctor” letter sent in the US by Novartis … [Read more...]